We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPCE:NYSEVirgin Galactic Holdings, Inc. Analysis

Data as of 2026-05-26 - not real-time

$3.24

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Virgin Galactic trades at $3.24, comfortably above its 20‑day (2.66) and 50‑day (2.67) SMAs but still below the 200‑day SMA (3.15), indicating a short‑term bounce within a longer‑term bearish framework. The RSI sits at 63, suggesting momentum remains healthy but not overbought, while a bullish MACD histogram (+0.028) adds technical support for upside. Volume is on an increasing trend, and the stock holds a clear support zone around $2.27 and resistance near $3.42, framing the current price range. However, the equity exhibits extreme volatility (103% 30‑day) and a high beta of 2.0, making price swings pronounced. Fundamentals are weak: the company is pre‑revenue, with negative operating cash flow, a debt‑to‑equity of 143%, and a net‑debt position of roughly $100 M, while the price‑to‑book (0.87) is below book value, hinting at a modest valuation cushion.
The most material catalyst is the announced schedule to begin Delta‑class flight testing in Q3 2026 and a rocket‑powered flight in Q4 2026, which could unlock commercial revenue streams and improve analyst sentiment. Consensus estimates show a modest upside of ~9.5% (median target $3.20, mean $3.55) amid an “Extreme Greed” market mood. Investors should weigh the upside from upcoming milestones against the high operational risk, debt load, and price volatility when forming a position.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and rising volume support a near‑term bounce
  • Price remains below 200‑day SMA, indicating broader bearish bias
  • High volatility and beta increase downside risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Scheduled Delta‑class test and Q4 rocket flight could trigger revenue
  • Analyst price targets imply modest upside
  • Improving technical momentum despite weak fundamentals

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑term growth potential in commercial space tourism
  • Significant debt load and ongoing cash burn
  • Regulatory and safety approvals remain uncertain

Key Metrics & Analysis

Financial Health

Revenue Growth-50.80%
P/E Ratio-6.7
ROE-104.51%
ROA-19.84%
Debt/Equity142.91
P/B Ratio0.9
Op. Cash Flow$-217724992
Free Cash Flow$-303645632
Industry P/E29.7

Technical Analysis

TrendBearish
RSI63.3
Support$2.27
Resistance$3.42
MA 20$2.66
MA 50$2.67
MA 200$3.15
MACDBullish
VolumeIncreasing
Fear & Greed Index91.77

Valuation

Target Price$3.55
Upside/Downside9.57%
GradeFair
TypeGrowth

Risk Assessment

Beta2.01
Volatility103.20%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.